{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-269992","form_type":"8-K","ticker":"CLPT","cik":"0001285550","company_name":"ClearPoint Neuro, Inc.","filed_at":"2025-11-06T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.028037+00:00","generated_at":"2026-05-16T23:23:51.124206+00:00","sec_items":["1.01","7.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"ClearPoint Neuro to acquire IRRAS for $5M cash + 1.325M shares; combined 2026 rev $54-60M","bullets":["Total consideration: $5M cash plus 1.325M ClearPoint shares; earnout of 25% of net IRRA flow sales above thresholds.","IRRAS's IRRA flow catheter addresses ~400K US procedures/yr, targeting a $0.5B global intracranial bleeding market.","IRRAS has >50 active customers and 83% growth in first 9 months of 2025 to ~$9M revenue run-rate.","Combined entity expected to have 40+ additional commercial professionals; 2026 revenue guidance $54M-$60M.","Transaction approved by both boards; closing conditions include IRRAS stockholder approval and Nasdaq Stockholm delisting by Dec 31, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-269992","json":"https://secwatch.observer/filing/0001193125-25-269992.json","markdown":"https://secwatch.observer/filing/0001193125-25-269992.md","text":"https://secwatch.observer/filing/0001193125-25-269992.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1285550/000119312525269992/0001193125-25-269992-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1285550/000119312525269992/clpt-20251106.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T23:23:51.124206+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}